Zobrazeno 1 - 10
of 2 177
pro vyhledávání: '"B-cell maturation"'
Autor:
Dimopoulos MA; Department of Clinical Therapeutics, National and Kapodistrian University of Athens, Athens, Greece., Migkou M; Department of Clinical Therapeutics, National and Kapodistrian University of Athens, Athens, Greece., Bhutani M; Atrium Health, Levine Cancer Institute, Charlotte, NC, USA., Ailawadhi S; Mayo Clinic, Jacksonville, FL, USA., Kalff A; The Alfred Hospital, Melbourne, Australia., Walcott FL; Early Oncology Research and Development, AstraZeneca, Gaithersburg, MD, USA., Pore N; Early Oncology Research and Development, AstraZeneca, Gaithersburg, MD, USA., Brown M; Early Oncology Research and Development, AstraZeneca, Gaithersburg, MD, USA., Wang F; Early Oncology Research and Development, AstraZeneca, Gaithersburg, MD, USA., Cheng LI; Clinical Pharmacology and Safety Sciences, BioPharmaceuticals Research and Development, AstraZeneca, Gaithersburg, MD, USA., Kagiampakis I; Translational Medicine Bioinformatics, AstraZeneca, Gaithersburg, MD, USA., Williams M; Translational Medicine, AstraZeneca, Gaithersburg, MD, USA., Kinneer K; Translational Medicine, AstraZeneca, Gaithersburg, MD, USA., Wu Y; Clinical Pharmacology and Safety Sciences, BioPharmaceuticals Research and Development, AstraZeneca, Gaithersburg, MD, USA., Jiang Y; Clinical Pharmacology and Safety Sciences, BioPharmaceuticals Research and Development, AstraZeneca, Gaithersburg, MD, USA., Kubiak RJ; Clinical Pharmacology and Safety Sciences, BioPharmaceuticals Research and Development, AstraZeneca, Gaithersburg, MD, USA., Zonder JA; Karmanos Cancer Institute, Detroit, MI, USA., Larsen J; Mayo Clinic, Scottsdale, AZ, USA., Sirdesai S; The Alfred Hospital, Melbourne, Australia., Yee AJ; Massachusetts General Hospital, Boston, MA, USA., Kumar S; Mayo Clinic, Rochester, MN, USA.
Publikováno v:
Leukemia & lymphoma [Leuk Lymphoma] 2024 Dec; Vol. 65 (12), pp. 1789-1800. Date of Electronic Publication: 2024 Oct 15.
Autor:
Supimon K; Siriraj Center of Research Excellence for Cancer Immunotherapy (SiCORE-CIT), Faculty of Medicine Siriraj Hospital, Mahidol University, Bangkok, Thailand; Division of Molecular Medicine, Research Department, Faculty of Medicine Siriraj Hospital, Mahidol, University, Bangkok, Thailand., Sangsuwannukul T; Department of Molecular Medicine, Mayo Clinic, Rochester, MN, United States. Electronic address: Sangsuwannukul.thanich@mayo.edu., Luangwattananun P; Siriraj Center of Research Excellence for Cancer Immunotherapy (SiCORE-CIT), Faculty of Medicine Siriraj Hospital, Mahidol University, Bangkok, Thailand; Division of Molecular Medicine, Research Department, Faculty of Medicine Siriraj Hospital, Mahidol, University, Bangkok, Thailand., Yenchitsomanus PT; Siriraj Center of Research Excellence for Cancer Immunotherapy (SiCORE-CIT), Faculty of Medicine Siriraj Hospital, Mahidol University, Bangkok, Thailand; Division of Molecular Medicine, Research Department, Faculty of Medicine Siriraj Hospital, Mahidol, University, Bangkok, Thailand. Electronic address: pathai.yen@mahidol.edu.
Publikováno v:
International immunopharmacology [Int Immunopharmacol] 2024 Dec 25; Vol. 143 (Pt 2), pp. 113480. Date of Electronic Publication: 2024 Oct 29.
Autor:
Merz M; Department of Hematology, Cellular Therapy, Hemasteseology and Infectious Disease, University Hospital of Leipzig and Fraunhofer IZI, Leipzig, Germany. maximilian.merz@medizin.uni-leipzig.de., Dima D; Cleveland Clinic, Cleveland, OH, USA.; US Myeloma Innovations Research Collaborative (USMIRC), Kansas City, MO, USA., Hashmi H; US Myeloma Innovations Research Collaborative (USMIRC), Kansas City, MO, USA.; The Medical University of South Carolina, Charleston, SC, USA.; Memorial Sloan Kettering Cancer Center, New York City, NY, USA., Ahmed N; US Myeloma Innovations Research Collaborative (USMIRC), Kansas City, MO, USA.; Division of Hematologic Malignancies & Cellular Therapeutics, University of Kansas Cancer Center, Westwood, KS, USA., Stölzel F; University Hospital Schleswig-Holstein Kiel, Kiel University, Kiel, Germany., Holderried TAW; Department of Hematology, Oncology, Stem Cell Transplantation, Immune and Cell Therapy, Clinical Immunology and Rheumatology, University Hospital Bonn, Bonn, Germany., Fenk R; Heinrich Heine University, University Hospital Düsseldorf, Düsseldorf, Germany., Müller F; Department of Internal Medicine 5, Haematology and Oncology, University Hospital of Erlangen, Friedrich-Alexander University of Erlangen-Nuremberg (FAU), Erlangen, Germany., Tovar N; Hospital Clínic de Barcelona. IDIBAPS. University of Barcelona, Barcelona, Spain., Oliver-Cáldes A; Hospital Clínic de Barcelona. IDIBAPS. University of Barcelona, Barcelona, Spain., Rathje K; University Medical Center Hamburg-Eppendorf, Hamburg, Germany., Davis JA; US Myeloma Innovations Research Collaborative (USMIRC), Kansas City, MO, USA.; The Medical University of South Carolina, Charleston, SC, USA., Fandrei D; Department of Hematology, Cellular Therapy, Hemasteseology and Infectious Disease, University Hospital of Leipzig and Fraunhofer IZI, Leipzig, Germany., Vucinic V; Department of Hematology, Cellular Therapy, Hemasteseology and Infectious Disease, University Hospital of Leipzig and Fraunhofer IZI, Leipzig, Germany., Kharboutli S; Department of Internal Medicine 5, Haematology and Oncology, University Hospital of Erlangen, Friedrich-Alexander University of Erlangen-Nuremberg (FAU), Erlangen, Germany., Baermann BN; Heinrich Heine University, University Hospital Düsseldorf, Düsseldorf, Germany., Ayuk F; University Medical Center Hamburg-Eppendorf, Hamburg, Germany., Platzbecker U; Department of Hematology, Cellular Therapy, Hemasteseology and Infectious Disease, University Hospital of Leipzig and Fraunhofer IZI, Leipzig, Germany., Albici AM; University Hospital Schleswig-Holstein Kiel, Kiel University, Kiel, Germany., Schub N; University Hospital Schleswig-Holstein Kiel, Kiel University, Kiel, Germany., Schmitz F; Department of Hematology, Oncology, Stem Cell Transplantation, Immune and Cell Therapy, Clinical Immunology and Rheumatology, University Hospital Bonn, Bonn, Germany., Shune L; Cleveland Clinic, Cleveland, OH, USA., Khouri J; Cleveland Clinic, Cleveland, OH, USA., Anwer F; Cleveland Clinic, Cleveland, OH, USA.; US Myeloma Innovations Research Collaborative (USMIRC), Kansas City, MO, USA., Raza S; Cleveland Clinic, Cleveland, OH, USA.; US Myeloma Innovations Research Collaborative (USMIRC), Kansas City, MO, USA., McGuirk J; US Myeloma Innovations Research Collaborative (USMIRC), Kansas City, MO, USA.; Division of Hematologic Malignancies & Cellular Therapeutics, University of Kansas Cancer Center, Westwood, KS, USA., Mahmoudjafari Z; US Myeloma Innovations Research Collaborative (USMIRC), Kansas City, MO, USA.; Division of Hematologic Malignancies & Cellular Therapeutics, University of Kansas Cancer Center, Westwood, KS, USA., Green K; US Myeloma Innovations Research Collaborative (USMIRC), Kansas City, MO, USA.; The Medical University of South Carolina, Charleston, SC, USA., Khandanpour C; Campus Lübeck, University Cancer Center Schleswig-Holstein and University of Lübeck, Lübeck, Germany., Teichert M; Department of Medicine II, Division for Stem Cell Transplantation and Cellular Immunotherapy, Universitätsklinikum Essen, Essen, Germany., Jeker B; Department of Medical Oncology, University Hospital Inselspital and University of Bern, Bern, Switzerland., Hoffmann M; Department of Medical Oncology, University Hospital Inselspital and University of Bern, Bern, Switzerland., Kröger N; University Medical Center Hamburg-Eppendorf, Hamburg, Germany., von Tresckow B; Department of Medicine II, Division for Stem Cell Transplantation and Cellular Immunotherapy, Universitätsklinikum Essen, Essen, Germany., de Larrea CF; Hospital Clínic de Barcelona. IDIBAPS. University of Barcelona, Barcelona, Spain., Pabst T; Department of Medical Oncology, University Hospital Inselspital and University of Bern, Bern, Switzerland., Abdallah AO; US Myeloma Innovations Research Collaborative (USMIRC), Kansas City, MO, USA.; Division of Hematologic Malignancies & Cellular Therapeutics, University of Kansas Cancer Center, Westwood, KS, USA., Gagelmann N; University Medical Center Hamburg-Eppendorf, Hamburg, Germany.
Publikováno v:
Blood cancer journal [Blood Cancer J] 2024 Dec 05; Vol. 14 (1), pp. 214. Date of Electronic Publication: 2024 Dec 05.
Autor:
Touzeau C; Department of Hematology, University Hospital Hôtel-Dieu, Nantes, France., Krishnan AY; Department of Hematology & Hematopoietic Cell Transplantation, City of Hope Comprehensive Cancer Center, Duarte, CA., Moreau P; Department of Hematology, University Hospital Hôtel-Dieu, Nantes, France., Perrot A; Service d'Hématologie, Centre Hospitalier, Universitaire de Toulouse, Toulouse, France., Usmani SZ; Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY., Manier S; Department of Hematology, University of Lille, Lille, France., Cavo M; IRCCS Azienda Ospedaliero-Universitaria di Bologna, Seràgnoli Institute of Hematology, Department of Medical and Surgical Sciences, Bologna University School of Medicine, Bologna, Italy., Martinez Chamorro C; Hematology Department, University Hospital Quirónsalud and Universidad Europea, Madrid, Spain., Nooka AK; Winship Cancer Institute, Emory University, Atlanta, GA., Martin TG; UCSF Helen Diller Family Comprehensive Cancer Center, San Francisco, CA., Karlin L; Service d'Hématologie Clinique, Centre Hospitalier Lyon Sud, Pierre-Bénite, France., Leleu X; Department of Hematology, Centre Hospitalier Universitaire de Poitiers, Poitiers, France., Bahlis NJ; Division of Hematology and Bone Marrow Transplantation, Arnie Charbonneau Cancer Institute, University of Calgary, Calgary, Canada., Besemer B; Department of Internal Medicine, University of Tubingen, Tubingen, Germany., Pei L; Janssen Research & Development, Raritan, NJ., Stein S; Janssen Research & Development, Philadelphia, PA., Wang Lin SX; Janssen Research & Development, Philadelphia, PA., Trancucci D; Janssen Research & Development, Raritan, NJ., Verona RI; Janssen Research & Development, Philadelphia, PA., Girgis S; Janssen Research & Development, Philadelphia, PA., Miao X; Janssen Research & Development, Philadelphia, PA., Uhlar CM; Janssen Research & Development, Philadelphia, PA., Chastain K; Janssen Research & Development, Raritan, NJ., Garfall AL; Division of Hematology Oncology, Abramson Cancer Center, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA.
Publikováno v:
Blood [Blood] 2024 Dec 05; Vol. 144 (23), pp. 2375-2388.
Autor:
Pan D; Tisch Cancer Institute, Icahn School of Medicine at Mount Sinai, 1 Gustave L. Levy Pl, New York, NY, 10029, USA., Richter J; Tisch Cancer Institute, Icahn School of Medicine at Mount Sinai, 1 Gustave L. Levy Pl, New York, NY, 10029, USA. Joshua.Richter@mountsinai.org.
Publikováno v:
Current hematologic malignancy reports [Curr Hematol Malig Rep] 2024 Dec; Vol. 19 (6), pp. 237-245. Date of Electronic Publication: 2024 Aug 15.
Autor:
Qi Y; Blood Diseases Institute Cancer Institute, Xuzhou Medical University, Xuzhou, China.; Department of Hematology, The Affiliated Hospital of Xuzhou Medical University, Xuzhou, China.; Jiangsu Key Laboratory of Bone Marrow Stem Cells, Xuzhou, China., Li H; Blood Diseases Institute Cancer Institute, Xuzhou Medical University, Xuzhou, China.; Department of Hematology, The Affiliated Hospital of Xuzhou Medical University, Xuzhou, China.; Jiangsu Key Laboratory of Bone Marrow Stem Cells, Xuzhou, China., Qi K; Blood Diseases Institute Cancer Institute, Xuzhou Medical University, Xuzhou, China.; Department of Hematology, The Affiliated Hospital of Xuzhou Medical University, Xuzhou, China.; Jiangsu Key Laboratory of Bone Marrow Stem Cells, Xuzhou, China., Zhu F; Blood Diseases Institute Cancer Institute, Xuzhou Medical University, Xuzhou, China.; Department of Hematology, The Affiliated Hospital of Xuzhou Medical University, Xuzhou, China.; Jiangsu Key Laboratory of Bone Marrow Stem Cells, Xuzhou, China., Cheng H; Blood Diseases Institute Cancer Institute, Xuzhou Medical University, Xuzhou, China.; Department of Hematology, The Affiliated Hospital of Xuzhou Medical University, Xuzhou, China.; Jiangsu Key Laboratory of Bone Marrow Stem Cells, Xuzhou, China., Chen W; Blood Diseases Institute Cancer Institute, Xuzhou Medical University, Xuzhou, China.; Department of Hematology, The Affiliated Hospital of Xuzhou Medical University, Xuzhou, China.; Jiangsu Key Laboratory of Bone Marrow Stem Cells, Xuzhou, China., Yan Z; Blood Diseases Institute Cancer Institute, Xuzhou Medical University, Xuzhou, China.; Department of Hematology, The Affiliated Hospital of Xuzhou Medical University, Xuzhou, China.; Jiangsu Key Laboratory of Bone Marrow Stem Cells, Xuzhou, China., Li D; Blood Diseases Institute Cancer Institute, Xuzhou Medical University, Xuzhou, China.; Department of Hematology, The Affiliated Hospital of Xuzhou Medical University, Xuzhou, China.; Jiangsu Key Laboratory of Bone Marrow Stem Cells, Xuzhou, China., Sang W; Blood Diseases Institute Cancer Institute, Xuzhou Medical University, Xuzhou, China.; Department of Hematology, The Affiliated Hospital of Xuzhou Medical University, Xuzhou, China.; Jiangsu Key Laboratory of Bone Marrow Stem Cells, Xuzhou, China., Fei X; Department of Hematology, The Affiliated Hospital of Jiangsu University, Zhenjiang, China., Gu W; Department of Hematology, The First People's Hospital of Changzhou, The Third Affiliated Hospital of Soochow University, Changzhou, China., Miao Y; Department of Hematology, The First People's Hospital of Yancheng, Yancheng, China., Huang H; Department of Hematology, The Affiliated Hospital of Nantong University, Nantong, China., Wang Y; Blood Diseases Institute Cancer Institute, Xuzhou Medical University, Xuzhou, China.; Department of Hematology, The Affiliated Hospital of Xuzhou Medical University, Xuzhou, China.; Jiangsu Key Laboratory of Bone Marrow Stem Cells, Xuzhou, China., Qiu T; Blood Diseases Institute Cancer Institute, Xuzhou Medical University, Xuzhou, China.; Department of Hematology, The Affiliated Hospital of Xuzhou Medical University, Xuzhou, China.; Jiangsu Key Laboratory of Bone Marrow Stem Cells, Xuzhou, China., Qiao J; Blood Diseases Institute Cancer Institute, Xuzhou Medical University, Xuzhou, China.; Department of Hematology, The Affiliated Hospital of Xuzhou Medical University, Xuzhou, China.; Jiangsu Key Laboratory of Bone Marrow Stem Cells, Xuzhou, China., Pan B; Blood Diseases Institute Cancer Institute, Xuzhou Medical University, Xuzhou, China.; Department of Hematology, The Affiliated Hospital of Xuzhou Medical University, Xuzhou, China.; Jiangsu Key Laboratory of Bone Marrow Stem Cells, Xuzhou, China., Shi M; Cancer Institute, Xuzhou Medical University, Xuzhou, China.; Jiangsu Center for the Collaboration and Innovation of Cancer Biotherapy, Xuzhou Medical University, Xuzhou, China.; Center of Clinical Oncology, The Affiliated Hospital of Xuzhou Medical University, Xuzhou, China., Wang G; Cancer Institute, Xuzhou Medical University, Xuzhou, China.; Jiangsu Center for the Collaboration and Innovation of Cancer Biotherapy, Xuzhou Medical University, Xuzhou, China.; Center of Clinical Oncology, The Affiliated Hospital of Xuzhou Medical University, Xuzhou, China., Li Z; Blood Diseases Institute Cancer Institute, Xuzhou Medical University, Xuzhou, China.; Department of Hematology, The Affiliated Hospital of Xuzhou Medical University, Xuzhou, China.; Jiangsu Key Laboratory of Bone Marrow Stem Cells, Xuzhou, China., Zheng J; Cancer Institute, Xuzhou Medical University, Xuzhou, China.; Jiangsu Center for the Collaboration and Innovation of Cancer Biotherapy, Xuzhou Medical University, Xuzhou, China.; Center of Clinical Oncology, The Affiliated Hospital of Xuzhou Medical University, Xuzhou, China., Xu K; Blood Diseases Institute Cancer Institute, Xuzhou Medical University, Xuzhou, China.; Department of Hematology, The Affiliated Hospital of Xuzhou Medical University, Xuzhou, China.; Jiangsu Key Laboratory of Bone Marrow Stem Cells, Xuzhou, China., Cao J; Blood Diseases Institute Cancer Institute, Xuzhou Medical University, Xuzhou, China.; Department of Hematology, The Affiliated Hospital of Xuzhou Medical University, Xuzhou, China.; Jiangsu Key Laboratory of Bone Marrow Stem Cells, Xuzhou, China.
Publikováno v:
American journal of hematology [Am J Hematol] 2024 Dec; Vol. 99 (12), pp. 2286-2295. Date of Electronic Publication: 2024 Aug 28.
Autor:
Bernardi C; Division of Haematology, Department of Oncology, Geneva University Hospitals, Geneva, Switzerland.; Translational Research Center for Oncohematology, Department of Medicine and Department of Pathology and Immunology, Faculty of Medicine, University of Geneva, Geneva, Switzerland., Beauverd Y; Division of Haematology, Department of Oncology, Geneva University Hospitals, Geneva, Switzerland., Tran TA; Division of Haematology, Department of Oncology, Geneva University Hospitals, Geneva, Switzerland., Maulini M; Division of Haematology, Department of Oncology, Geneva University Hospitals, Geneva, Switzerland., Mappoura M; Division of Haematology, Department of Oncology, Geneva University Hospitals, Geneva, Switzerland., Morin S; Division of Haematology, Department of Oncology, Geneva University Hospitals, Geneva, Switzerland., Simonetta F; Division of Haematology, Department of Oncology, Geneva University Hospitals, Geneva, Switzerland.; Translational Research Center for Oncohematology, Department of Medicine and Department of Pathology and Immunology, Faculty of Medicine, University of Geneva, Geneva, Switzerland., Cairoli A; Division of Haematology, Department of Oncology, University Hospital of Lausanne (CHUV), Lausanne, Switzerland., Auner HW; Division of Haematology, Department of Oncology, University Hospital of Lausanne (CHUV), Lausanne, Switzerland., Samii K; Division of Haematology, Department of Oncology, Geneva University Hospitals, Geneva, Switzerland., Chalandon Y; Division of Haematology, Department of Oncology, Geneva University Hospitals, Geneva, Switzerland., de Ramon Ortiz C; Division of Haematology, Department of Oncology, Geneva University Hospitals, Geneva, Switzerland.
Publikováno v:
Frontiers in immunology [Front Immunol] 2024 Nov 29; Vol. 15, pp. 1495233. Date of Electronic Publication: 2024 Nov 29 (Print Publication: 2024).
Autor:
Guo J; Division of Life Science and State Key Lab of Molecular Neuroscience, Hong Kong University of Science and Technology, Hong Kong, Hong Kong SAR, China.; Guangzhou Bay Area Institute of Biomedicine, Guangdong Lewwin Pharmaceutical Research Institute Co.,Ltd., Guangdong Provincial Key Laboratory of Drug Non-Clinical Evaluation and Research, Guangdong Engineering Research Center for Innovative Drug Evaluation and Research, Guangzhou, China.; Guangdong Engineering Research Center for Cellular and Genetic Therapy Innovative Drugs, Shenzhen, China., Wu Q; Guangzhou Bay Area Institute of Biomedicine, Guangdong Lewwin Pharmaceutical Research Institute Co.,Ltd., Guangdong Provincial Key Laboratory of Drug Non-Clinical Evaluation and Research, Guangdong Engineering Research Center for Innovative Drug Evaluation and Research, Guangzhou, China.; College of Pharmacy, Guilin Medical University, Guilin, China., Li H; Guangdong Engineering Research Center for Cellular and Genetic Therapy Innovative Drugs, Shenzhen, China.; Shenzhen Pregene Biopharma Company Ltd., Research and Development (R&D) Department, Shenzhen, China., Liang C; Division of Life Science and State Key Lab of Molecular Neuroscience, Hong Kong University of Science and Technology, Hong Kong, Hong Kong SAR, China., Dai J; Guangzhou Bay Area Institute of Biomedicine, Guangdong Lewwin Pharmaceutical Research Institute Co.,Ltd., Guangdong Provincial Key Laboratory of Drug Non-Clinical Evaluation and Research, Guangdong Engineering Research Center for Innovative Drug Evaluation and Research, Guangzhou, China.; Guangdong Engineering Research Center for Cellular and Genetic Therapy Innovative Drugs, Shenzhen, China., Zhang S; Guangzhou Bay Area Institute of Biomedicine, Guangdong Lewwin Pharmaceutical Research Institute Co.,Ltd., Guangdong Provincial Key Laboratory of Drug Non-Clinical Evaluation and Research, Guangdong Engineering Research Center for Innovative Drug Evaluation and Research, Guangzhou, China.; Guangdong Engineering Research Center for Cellular and Genetic Therapy Innovative Drugs, Shenzhen, China., Dai C; Guangzhou Bay Area Institute of Biomedicine, Guangdong Lewwin Pharmaceutical Research Institute Co.,Ltd., Guangdong Provincial Key Laboratory of Drug Non-Clinical Evaluation and Research, Guangdong Engineering Research Center for Innovative Drug Evaluation and Research, Guangzhou, China.; Guangdong Engineering Research Center for Cellular and Genetic Therapy Innovative Drugs, Shenzhen, China., Zhang J; Guangzhou Bay Area Institute of Biomedicine, Guangdong Lewwin Pharmaceutical Research Institute Co.,Ltd., Guangdong Provincial Key Laboratory of Drug Non-Clinical Evaluation and Research, Guangdong Engineering Research Center for Innovative Drug Evaluation and Research, Guangzhou, China.; Guangdong Engineering Research Center for Cellular and Genetic Therapy Innovative Drugs, Shenzhen, China., Wen Y; Guangzhou Bay Area Institute of Biomedicine, Guangdong Lewwin Pharmaceutical Research Institute Co.,Ltd., Guangdong Provincial Key Laboratory of Drug Non-Clinical Evaluation and Research, Guangdong Engineering Research Center for Innovative Drug Evaluation and Research, Guangzhou, China.; Guangdong Engineering Research Center for Cellular and Genetic Therapy Innovative Drugs, Shenzhen, China., Yang W; Division of Life Science and State Key Lab of Molecular Neuroscience, Hong Kong University of Science and Technology, Hong Kong, Hong Kong SAR, China.; Guangzhou Bay Area Institute of Biomedicine, Guangdong Lewwin Pharmaceutical Research Institute Co.,Ltd., Guangdong Provincial Key Laboratory of Drug Non-Clinical Evaluation and Research, Guangdong Engineering Research Center for Innovative Drug Evaluation and Research, Guangzhou, China.; Guangdong Engineering Research Center for Cellular and Genetic Therapy Innovative Drugs, Shenzhen, China.
Publikováno v:
Frontiers in immunology [Front Immunol] 2024 Nov 13; Vol. 15, pp. 1435934. Date of Electronic Publication: 2024 Nov 13 (Print Publication: 2024).
Autor:
Zhou Z; Department of Hematology, The Second Hospital of Hebei Medical University, Shijiazhuang, China., Liu X; Department of Hematology, The Second Hospital of Hebei Medical University, Shijiazhuang, China., Zhang X; Department of Hematology, The Second Hospital of Hebei Medical University, Shijiazhuang, China., Wen S; Department of Hematology, The Second Hospital of Hebei Medical University, Shijiazhuang, China., Hua H; Department of Hematology, The Second Hospital of Hebei Medical University, Shijiazhuang, China., Xu Z; Department of Hematology, The Second Hospital of Hebei Medical University, Shijiazhuang, China., Wang F; Department of Hematology, The Second Hospital of Hebei Medical University, Shijiazhuang, China. Electronic address: wfxhebmu@163.com.
Publikováno v:
Transplantation and cellular therapy [Transplant Cell Ther] 2024 Nov; Vol. 30 (11), pp. 1080.e1-1080.e11. Date of Electronic Publication: 2024 Sep 03.
Autor:
Fu B; Department of Hematology, The Second Affiliated Hospital of Xi'an Jiaotong University, Xi'an, China., Liu R; Department of Hematology, The Second Affiliated Hospital of Xi'an Jiaotong University, Xi'an, China., Gao G; Department of Hematology, The Second Affiliated Hospital of Xi'an Jiaotong University, Xi'an, China., Lin Z; Department of Hematology, The Second Affiliated Hospital of Xi'an Jiaotong University, Xi'an, China., He A; Department of Hematology, The Second Affiliated Hospital of Xi'an Jiaotong University, Xi'an, China.; National-Local Joint Engineering Research Center of Biodiagnostics & Biotherapy, The Second Affiliated Hospital of Xi'an Jiaotong University, Xi'an, China.; Xi'an Key Laboratory of Hematological Diseases, Xi'an, China.
Publikováno v:
Frontiers in immunology [Front Immunol] 2024 Oct 22; Vol. 15, pp. 1433774. Date of Electronic Publication: 2024 Oct 22 (Print Publication: 2024).